HF Advisory Group LLC grew its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 73.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,345 shares of the enterprise software provider's stock after buying an additional 5,231 shares during the period. HF Advisory Group LLC's holdings in Oracle were worth $1,816,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in ORCL. Welch Group LLC raised its position in shares of Oracle by 9.3% during the 1st quarter. Welch Group LLC now owns 74,617 shares of the enterprise software provider's stock valued at $10,977,000 after buying an additional 6,331 shares in the last quarter. Piedmont Capital Management LLC NC grew its position in Oracle by 14.8% in the first quarter. Piedmont Capital Management LLC NC now owns 4,352 shares of the enterprise software provider's stock worth $640,000 after acquiring an additional 560 shares in the last quarter. Wesbanco Bank Inc. grew its position in Oracle by 3.7% in the first quarter. Wesbanco Bank Inc. now owns 89,367 shares of the enterprise software provider's stock worth $13,147,000 after acquiring an additional 3,169 shares in the last quarter. Unique Wealth LLC increased its stake in Oracle by 6.5% in the first quarter. Unique Wealth LLC now owns 2,009 shares of the enterprise software provider's stock valued at $296,000 after acquiring an additional 122 shares during the last quarter. Finally, Topsail Wealth Management LLC raised its position in Oracle by 4.2% during the first quarter. Topsail Wealth Management LLC now owns 1,903 shares of the enterprise software provider's stock valued at $280,000 after purchasing an additional 76 shares in the last quarter. Institutional investors own 42.44% of the company's stock.
Trending Headlines about Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle Health and Theator announced an AI-powered surgical reporting partnership, adding another real-world use case for Oracle Cloud Infrastructure in healthcare. Oracle Health (ORCL), Theator Partner to Automate Surgical Reporting with AI
- Positive Sentiment: Several recent articles highlighted Oracle’s massive contract backlog and strong AI cloud demand, arguing the company has improved long-term revenue visibility despite near-term volatility. Oracle's Contract Backlog Swells: Is Long-Term Revenue Growth Secured?
- Positive Sentiment: Wall Street sentiment remains broadly constructive, with coverage pointing to dozens of buy ratings and meaningful upside from current levels. Oracle stock has worst week since 2001 dot-com bust as AI financing concerns escalate
- Neutral Sentiment: Oracle was also featured in commentary suggesting the recent sell-off may be overdone and more a valuation/mispricing issue than a fundamental break in the AI story. Oracle's Market Disconnect: The Truth Can Make You Rich
- Negative Sentiment: Investor concern is centered on Oracle’s aggressive AI spending: capital expenditures surged, free cash flow turned deeply negative, and debt is now high, raising questions about financing the buildout. Oracle stock has worst week since 2001 dot-com bust as AI financing concerns escalate
- Negative Sentiment: OpenAI IPO delay fears weighed on Oracle and other AI-related stocks, since Oracle is tied to the broader AI infrastructure trade. OpenAI May Push Back Highly-Awaited IPO to 2027, Slamming SoftBank and Oracle Shares
- Negative Sentiment: Oracle Vice Chairman Jeffrey Henley sold 400,000 shares in a pre-arranged 10b5-1 plan, a headline that can add to sentiment pressure even if the sale was scheduled. SEC filing for Jeffrey Henley stock sale
Insider Activity
In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the transaction, the insider owned 400,000 shares of the company's stock, valued at $63,664,000. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Stuart Levey sold 15,000 shares of the stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total value of $2,642,850.00. Following the completion of the sale, the executive vice president owned 3,429 shares of the company's stock, valued at approximately $604,155.51. This trade represents a 81.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have issued reports on the company. Citigroup reaffirmed a "market outperform" rating on shares of Oracle in a research note on Thursday, June 11th. Barclays increased their price objective on Oracle from $240.00 to $250.00 and gave the company an "overweight" rating in a research report on Thursday, June 11th. Stifel Nicolaus decreased their price objective on Oracle from $275.00 to $220.00 and set a "buy" rating on the stock in a report on Wednesday, March 11th. Deutsche Bank Aktiengesellschaft cut their target price on Oracle from $375.00 to $300.00 and set a "buy" rating for the company in a research note on Monday, March 9th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $284.00 price target on shares of Oracle in a research report on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Oracle currently has an average rating of "Moderate Buy" and a consensus price target of $268.27.
View Our Latest Research Report on Oracle
Oracle Trading Down 2.5%
NYSE:ORCL opened at $148.68 on Friday. The company has a fifty day moving average of $189.53 and a 200 day moving average of $175.69. Oracle Corporation has a 52 week low of $134.57 and a 52 week high of $345.72. The company has a quick ratio of 1.35, a current ratio of 1.12 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of $428.27 billion, a P/E ratio of 25.50, a P/E/G ratio of 0.96 and a beta of 1.65.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.15. The business had revenue of $19.18 billion during the quarter, compared to analysts' expectations of $19.10 billion. Oracle had a net margin of 25.37% and a return on equity of 58.62%. The firm's revenue for the quarter was up 20.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.70 EPS. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. On average, research analysts predict that Oracle Corporation will post 6.45 earnings per share for the current year.
Oracle Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Stockholders of record on Friday, July 10th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Friday, July 10th. Oracle's dividend payout ratio is currently 34.31%.
About Oracle
(
Free Report)
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Articles
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report